vs
Alector, Inc.（ALEC）与CaliberCos Inc.（CWD）财务数据对比。点击上方公司名可切换其他公司
Alector, Inc.的季度营收约是CaliberCos Inc.的1.5倍（$6.2M vs $4.1M），CaliberCos Inc.同比增速更快（-52.5% vs -88.5%），过去两年Alector, Inc.的营收复合增速更高（-37.4% vs -57.6%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
CaliberCos Inc.是一家总部位于美国的另类资产管理企业，核心业务涵盖房地产投资、资产运营及增值开发板块，服务对象包含机构投资者、高净值人群与零售投资者，业务布局主要集中在北美地区。
ALEC vs CWD — 直观对比
营收规模更大
ALEC
是对方的1.5倍
$4.1M
营收增速更快
CWD
高出36.0%
-88.5%
两年增速更快
ALEC
近两年复合增速
-57.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $4.1M |
| 净利润 | — | $-7.7M |
| 毛利率 | — | — |
| 营业利润率 | — | -196.6% |
| 净利率 | — | -188.3% |
| 营收同比 | -88.5% | -52.5% |
| 净利润同比 | -1696.9% | 32.2% |
| 每股收益（稀释后） | — | $1.95 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECCWD
| Q4 25 | $6.2M | $4.1M | ||
| Q3 25 | $3.3M | $3.6M | ||
| Q2 25 | $7.9M | $5.1M | ||
| Q1 25 | $3.7M | $7.3M | ||
| Q4 24 | $54.2M | $8.7M | ||
| Q3 24 | $15.3M | $11.3M | ||
| Q2 24 | $15.1M | $8.2M | ||
| Q1 24 | $15.9M | $23.0M |
净利润ALECCWD
| Q4 25 | — | $-7.7M | ||
| Q3 25 | $-34.7M | $-4.4M | ||
| Q2 25 | $-30.5M | $-5.3M | ||
| Q1 25 | $-40.5M | $-4.4M | ||
| Q4 24 | $-2.1M | $-11.4M | ||
| Q3 24 | $-42.2M | $146.0K | ||
| Q2 24 | $-38.7M | $-4.7M | ||
| Q1 24 | $-36.1M | $-3.8M |
营业利润率ALECCWD
| Q4 25 | — | -196.6% | ||
| Q3 25 | -1153.6% | -129.6% | ||
| Q2 25 | -433.6% | -112.4% | ||
| Q1 25 | -1216.5% | -62.7% | ||
| Q4 24 | -13.4% | -236.8% | ||
| Q3 24 | -315.7% | 0.0% | ||
| Q2 24 | -302.4% | -65.0% | ||
| Q1 24 | -275.0% | -22.9% |
净利率ALECCWD
| Q4 25 | — | -188.3% | ||
| Q3 25 | -1063.4% | -120.2% | ||
| Q2 25 | -387.7% | -104.5% | ||
| Q1 25 | -1101.6% | -60.7% | ||
| Q4 24 | -3.8% | -247.6% | ||
| Q3 24 | -275.2% | 1.3% | ||
| Q2 24 | -256.4% | -57.8% | ||
| Q1 24 | -227.0% | -16.6% |
每股收益（稀释后）ALECCWD
| Q4 25 | — | $1.95 | ||
| Q3 25 | $-0.34 | $-1.65 | ||
| Q2 25 | $-0.30 | $-4.15 | ||
| Q1 25 | $-0.41 | $-3.85 | ||
| Q4 24 | $-0.02 | $-10.15 | ||
| Q3 24 | $-0.43 | $0.12 | ||
| Q2 24 | $-0.40 | $-4.34 | ||
| Q1 24 | $-0.38 | $-3.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $2.9M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $30.6M | $1.3M |
| 总资产 | $293.2M | $135.4M |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALECCWD
| Q4 25 | $256.0M | $2.9M | ||
| Q3 25 | $291.1M | $10.9M | ||
| Q2 25 | $307.3M | $683.0K | ||
| Q1 25 | $354.6M | $1.6M | ||
| Q4 24 | $413.4M | $2.3M | ||
| Q3 24 | $457.2M | $1.6M | ||
| Q2 24 | $503.3M | $1.8M | ||
| Q1 24 | $562.1M | $2.1M |
总债务ALECCWD
| Q4 25 | $10.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALECCWD
| Q4 25 | $30.6M | $1.3M | ||
| Q3 25 | $57.7M | $4.2M | ||
| Q2 25 | $71.2M | $-19.9M | ||
| Q1 25 | $94.6M | $-15.8M | ||
| Q4 24 | $126.8M | $-12.6M | ||
| Q3 24 | $118.9M | $-3.8M | ||
| Q2 24 | $150.6M | $-4.7M | ||
| Q1 24 | $178.9M | $-745.0K |
总资产ALECCWD
| Q4 25 | $293.2M | $135.4M | ||
| Q3 25 | $335.3M | $82.6M | ||
| Q2 25 | $356.4M | $59.3M | ||
| Q1 25 | $408.3M | $103.6M | ||
| Q4 24 | $468.3M | $105.5M | ||
| Q3 24 | $516.0M | $158.6M | ||
| Q2 24 | $570.7M | $195.2M | ||
| Q1 24 | $635.5M | $201.5M |
负债/权益比ALECCWD
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $-12.1M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | — |
| 自由现金流率自由现金流/营收 | -2951.3% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-326.5M | — |
8季度趋势，按日历期对齐
经营现金流ALECCWD
| Q4 25 | $-184.0M | $-12.1M | ||
| Q3 25 | $-32.5M | $-4.6M | ||
| Q2 25 | $-49.0M | $-1.2M | ||
| Q1 25 | $-60.8M | $-1.7M | ||
| Q4 24 | $-55.0M | $555.0K | ||
| Q3 24 | $-50.7M | $-74.0K | ||
| Q2 24 | $-62.8M | $1.4M | ||
| Q1 24 | $-61.3M | $-1.5M |
自由现金流ALECCWD
| Q4 25 | $-184.1M | — | ||
| Q3 25 | $-32.5M | — | ||
| Q2 25 | $-49.1M | — | ||
| Q1 25 | $-60.8M | — | ||
| Q4 24 | $-55.2M | — | ||
| Q3 24 | $-50.9M | — | ||
| Q2 24 | $-63.1M | — | ||
| Q1 24 | $-61.9M | — |
自由现金流率ALECCWD
| Q4 25 | -2951.3% | — | ||
| Q3 25 | -997.6% | — | ||
| Q2 25 | -623.0% | — | ||
| Q1 25 | -1655.0% | — | ||
| Q4 24 | -101.8% | — | ||
| Q3 24 | -332.1% | — | ||
| Q2 24 | -418.6% | — | ||
| Q1 24 | -389.3% | — |
资本支出强度ALECCWD
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 3.4% | — |
现金转化率ALECCWD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.51× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
